Jul 29, 2022
In this podcast, alternative models of cardiac rehabilitation (CR) are discussed by Drs. Brown and Tracy, with Dr. Forman serving as moderator. The rationale for the needs for remote and hybrid models of care are presented, as well as the definitions of what these alternative models should be (incorporating all of the...
Jul 15, 2022
In this episode, Drs. Matt Martinez and Theodore Abraham discuss “What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten” for the treatment of hypertrophic cardiomyopathy, and its mechanisms of action.
Jul 8, 2022
Are you trying to decide if the Collaborative Maintenance Pathway (CMP) is for you? When it comes to meeting maintenance of certification (MOC) requirements, you have choices! Thousands of your peers have chosen to participate in the CMP. Listen to this interview detailing participants personal experiences and insights.
Jun 17, 2022
In this episode, Drs. Matt Martinez and Ahmad Masri discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and mechanisms of action.
Jun 6, 2022
In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Dr. Tammy Brady discusses the numerous, often ignored, factors that can lead to inaccurate blood pressure assessment and the degree to which this may affect clinical management. Topics will include cuff...